72 related articles for article (PubMed ID: 27821443)
21. Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections.
Cowell AN; Winzeler EA
Genome Med; 2019 Oct; 11(1):63. PubMed ID: 31640748
[TBL] [Abstract][Full Text] [Related]
22. Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733.
Crawford ED; Quan J; Horst JA; Ebert D; Wu W; DeRisi JL
PLoS One; 2017; 12(5):e0178163. PubMed ID: 28542423
[TBL] [Abstract][Full Text] [Related]
23. Studies on plasmepsins I and II from the malarial parasite Plasmodium falciparum and their exploitation as drug targets.
Moon RP; Bur D; Loetscher H; D'Arcy A; Tyas L; Oefner C; Grueninger-Leitch F; Mona D; Rupp K; Dorn A; Matile H; Certa U; Berry C; Kay J; Ridley RG
Adv Exp Med Biol; 1998; 436():397-406. PubMed ID: 9561248
[No Abstract] [Full Text] [Related]
24. Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors Interactions.
Miller Iii WA; Teye J; Achieng AO; Mogire RM; Akala H; Ong'echa JM; Rathi B; Durvasula R; Kempaiah P; Kwofie SK
Curr Top Med Chem; 2019; 18(23):2022-2028. PubMed ID: 30499404
[TBL] [Abstract][Full Text] [Related]
25. Altered Plasmodium falciparum Sensitivity to the Antiretroviral Protease Inhibitor Lopinavir Associated with Polymorphisms in pfmdr1.
Sonoiki E; Nsanzabana C; Legac J; Sindhe KM; DeRisi J; Rosenthal PJ
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821443
[TBL] [Abstract][Full Text] [Related]
26. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.
Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine.
Mukherjee A; Gagnon D; Wirth DF; Richard D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439977
[TBL] [Abstract][Full Text] [Related]
28. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
[TBL] [Abstract][Full Text] [Related]
29. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors.
Parikh S; Gut J; Istvan E; Goldberg DE; Havlir DV; Rosenthal PJ
Antimicrob Agents Chemother; 2005 Jul; 49(7):2983-5. PubMed ID: 15980379
[TBL] [Abstract][Full Text] [Related]
30. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
31. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
Sonoiki E; Palencia A; Guo D; Ahyong V; Dong C; Li X; Hernandez VS; Zhang YK; Choi W; Gut J; Legac J; Cooper R; Alley MR; Freund YR; DeRisi J; Cusack S; Rosenthal PJ
Antimicrob Agents Chemother; 2016 Aug; 60(8):4886-95. PubMed ID: 27270277
[TBL] [Abstract][Full Text] [Related]
32. Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin V.
Gazdik M; Jarman KE; O'Neill MT; Hodder AN; Lowes KN; Jousset Sabroux H; Cowman AF; Boddey JA; Sleebs BE
Bioorg Med Chem; 2016 May; 24(9):1993-2010. PubMed ID: 27021426
[TBL] [Abstract][Full Text] [Related]
33. Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X.
Li F; Bounkeua V; Pettersen K; Vinetz JM
Malar J; 2016 Feb; 15():111. PubMed ID: 26911483
[TBL] [Abstract][Full Text] [Related]
34. Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.
Rasina D; Otikovs M; Leitans J; Recacha R; Borysov OV; Kanepe-Lapsa I; Domraceva I; Pantelejevs T; Tars K; Blackman MJ; Jaudzems K; Jirgensons A
J Med Chem; 2016 Jan; 59(1):374-87. PubMed ID: 26670264
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral therapy: current drugs.
Pau AK; George JM
Infect Dis Clin North Am; 2014 Sep; 28(3):371-402. PubMed ID: 25151562
[TBL] [Abstract][Full Text] [Related]
36. Gene disruption reveals a dispensable role for plasmepsin VII in the Plasmodium berghei life cycle.
Mastan BS; Kumari A; Gupta D; Mishra S; Kumar KA
Mol Biochem Parasitol; 2014 Jun; 195(1):10-3. PubMed ID: 24893340
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
